私たちのチーム TEAM
HUMACOLOGY製品は、
医師、植物学者、科学者を含む専門チームが開発を手がけ、
厳格な監修のもと高水準な管理体制を築いています。
At its GMP-certified factory in Greece,
industry experts, including doctors, phytochemists, and scientists,
oversee every stage of production and quality control.
2020年に、私たちは高品質で手頃な価格のCBD製品を目指し、HUMACOLOGYブランドをオーストラリアで立ちあげました。豊富なテルペンを含む高濃度CBDオイルを自社工場で製造することで、品質の安定と安定供給を実現しています。
In 2020, we launched Humacology in Australia with the goal of offering high-quality, affordable CBD products. By producing high-concentration CBD oil rich in terpenes at our own factory, we ensure consistent quality and a stable supply.
現在、HUMACOLOGYはオーストラリアで25,000人以上に支持されるNo.1ブランドとなりました。このたび日本の皆さまにもお届けできる機会をいただき、大変光栄に思っております。ぜひお試しいただければ幸いです。
Today, Humacology has become the No.1 brand supported by over 25,000 users in Australia. We are truly honored to have the opportunity to bring our products to customers in Japan and sincerely hope you will give them a try.
CCO（チーフ・クリエーション・オフィサー）
CCO (Chief Creation Officer)
Sam Saunders
サム・ソーンダース
DR.CROSBY RECHTIN
クロスビー・レヒティン医師
DR.CROSBY RECHTIN
医療統括責任者 / 共同創設者
CHIEF MEDICAL OFFICER + CO-FOUNDER
救急医療、カンナビノイド医療、救急搬送医療を専門とする医師。2007年にルイビル大学医学部（University of Louisville School of Medicine）を卒業し、2010年にミシガン州グランドラピッズで救急医学のレジデンシーを修了。米国救急医師学会（American College of Emergency Physicians）のフェロー認定を取得し、2013年のオーストラリア移住後はオーストララシアン救急医師学会（Australasian College for Emergency Medicine）のフェローに認定。2010年より医療用カンナビスの処方を行い、近年までオーストラリアの著名なカンナビスクリニックでカンナビノイド医療に従事。TGA（オーストラリア医薬品医療製品局）認可の医療用カンナビス処方医として患者ケアを行う一方、医療用カンナビスの教育や研究にも携わる。世界各地の団体と連携し、一般開業医向け継続教育コンテンツも制作。医療用カンナビスの高コストが効果的な治療への障壁であると考え、The CBD Guys と協力して、質の高い低コスト医薬品の提供に取り組む。
Dr. Rechtin is a physician specializing in Emergency Medicine, Cannabinoid Medicine, and Retrieval Medicine. He graduated from the University of Louisville School of Medicine in 2007 and completed his residency in Emergency Medicine in Grand Rapids, Michigan in 2010. He became a Fellow of the American College of Emergency Physicians and upon moving to Australia in 2013 a Fellow of the Australasian College for Emergency Medicine. Crosby has been prescribing medicinal cannabis since 2010 and until recently practiced Cannabinoid Medicine with a renowned cannabis clinic in Australia. In addition to direct patient care and recognition by the TGA as an Authorised Prescriber of medicinal cannabis, Crosby is involved in medical cannabis education and research. He has worked with numerous organisations all over the world to help create continuing medical education content for prescribers, including the Royal Australasian College of General Practitioners. Crosby is convinced the cost of medicinal cannabis products is a barrier to effective care, which is why he's working with The CBD Guys to create quality, cost-effective medicine for all Australians.
DR. SHEETAL BULL
シータル・ブル医師
DR. SHEETAL BULL
研究開発統括責任者
CHIEF SCIENTIFIC OFFICER
一般診療、精神医学、カンナビノイド医療を専門とする医師。医療・臨床研究分野で幅広い経験を持ち、臨床現場だけでなく医療提供のマネジメントや事業開発にも従事。英国王立精神科医協会（The Royal College of Psychiatrists, UK）のメンバーで、精神科領域での豊富な経験を有する。精神医学の大学院学位（PgDip Psych）も取得。臨床試験の運営に特化したサイト管理組織 Paratus Clinical の主任研究者（Principal Investigator）を務め、医療用カンナビス分野における専門的知見を有する。一般診療医としても勤務し、メンタルヘルスや先住民医療に注力。さらに、MONDAY–SUNDAY by HUMACOLOGY の最高医療責任者として、非CBD自然医薬品ブランドのグローバル展開にも関与。
Dr. Bull is a Medical doctor within General Practice, Psychiatry and Cannabinoid Medicine. He has extensive experience in the healthcare and clinical research sectors and also extensive involvement in both the hands-on clinical work and management/business development of healthcare provision. Dr Bull is a member of The Royal College of Psychiatrists (UK) with a number of years experience within Psychiatry. Further postgraduate degree in Psychiatry - PgDip Psych. Dr Bull is also Principal Investigator for Paratus Clinical, a site management organisation that is focused on the recruitment and running of clinical trials. He is an expert cannabinoid clinician, with experience in the emerging role within Medicinal Cannabis, as well as working as a general practice doctor, with a focus on mental health and Indigenous health. Business consultant within the healthcare and property development sectors. Dr Bull also works as Chief Medical Officer for MONDAY–SUNDAY by HUMACOLOGY, a natural, non-CBD medicine brand sold globally.
DR. NIKOLAS FOKLIAKIS
ニコラス・フォクリアキス博士
DR. NIKOLAS FOKLIAKIS
植物化学者 / 処方開発統括責任者
PHYTOCHEMIST + FORMULATOR
国立アテネ大学 薬用資源学・天然物化学の准教授であり、薬用植物・天然物研究学会（Society for Medicinal Plant and Natural Product Research, GA）の副会長、American Society of Pharmacognosy（アメリカ薬用資源学会）、Association Francophone pour l’Enseignement et la Recherche en Pharmacognosie（フランス語圏薬用資源学教育研究協会）会員。過去にはマイアミ大学で客員教授を歴任し、現在ではカンナビノイド医薬や特にテルペンに関する国際的な講演者として高い評価を得ている。また、マイナー・カンナビノイドおよびテルペン研究の世界的権威の一人として知られ、その知見はHumacologyの医薬品開発や、MONDAY-SUNDAY by HUMACOLOGYの製品づくりにも活かされている。
Dr. Fokliakis is an Associate Professor of Pharmacognosy & Natural Products Chemistry at National and Kapodistrian University of Athens and the Vice President of Society for Medicinal Plant and Natural Product Research. Before that, Dr. Fokliakis was a visiting professor at the University of Miami, and today is in high-demand as an international speaker on cannabinoid medicines and terpenes in particular. Dr. Fokliakis is considered to be one of the world’s preeminent thought leaders around minor cannabinoids and terpenes, and uses this knowledge for Humacology medicines as well as MONDAY–SUNDAY by HUMACOLOGY medicines.
JOSEPH CORCORAN, C.N.
ジョセフ・コーコラン臨床看護師
JOSEPH CORCORAN, C.N.
ゼネラルマネージャー / パートナー
GENERAL MANAGER + PARTNER
アイルランド出身の臨床看護師。トリニティ・カレッジ・ダブリン（Trinity College Dublin）セントジェームス病院DNSプログラムで研修を受け、20年以上にわたり幅広い看護経験を積む。自然療法に深い関心を持ち、個別ケアに定評がある。医療・外科看護、先住民医療、がん治療、透析、緩和ケアに従事し、複数の医療施設で臨床管理者も経験。さらに、不安障害・うつ病のケアに精通し、自殺予防のASISTカウンセラー資格も有する。現在はオーストラリアのヌーサやメルボルンだけでなく、アイルランド、カリフォルニアを拠点に活動する。
Nurse Joe is an Irish-born and -trained Clinical Nurse with over two decades of experience in the field of healthcare. He trained at Trinity College Dublin in the St James Hospital DNS Program, and this top-tier training continues to inform his practice today. His wellness journey has now led him to the world of natural medicines, and he firmly believes nature's remedies can profoundly benefit those seeking healing and betterment. Joe has extensive nursing experience covering in-depth and personalised patient care. He is very well-known for his exceptional bedside manner and attention to detail. His broad career has covered medical/surgical nursing, Indigenous health, specialised cancer care and dialysis nursing, through to end of life palliative care. In his work, Joe has also managed several medical facilities along the way as a clinical administrator. Joe is additionally very well-versed in anxiety and depressive disorders, and is a fully trained ASIST Counsellor for suicide prevention. Today, Joe bases himself between Noosa, Melbourne, Ireland and California.
SAM SAUNDERS
サム・ソーンダース
SAM SAUNDERS
チーフ クリエーション オフィサー / 共同創設者
CHIEF CREATION OFFICER + CO-FOUNDER
世界的に評価されるクリエイティブリーダー。広告、製品開発、ブランド体験、映像・コンテンツ制作など幅広く活躍。オスカー受賞監督ミシェル・ゴンドリーによるTVC制作や、カンヌ・One Show受賞歴も持つ。過去6年間で複数ブランド（Canvino, Cangria, BUMP, Babycakes, Nudge Nudge Wink Wink, The CBD Guys, Humacology, MONDAY–SUNDAY, DiscoLabs）を共同創業。国際的に講演活動も行い、カンヌライオンズでは16回登壇。広告業界では M&C Saatchi, SS&K, JWT, VMLY&R, Apple, We Are Social などで北米チーフクリエーションオフィサーを務め、複数の広告代理店を創業・売却。孤児支援団体 Hopeland の共同設立者。現在はヌーサ、メルボルン、東京を拠点に活動。
Sam is a globally-recognized, well-liked and -respected creative leader who has worked across almost every industry and medium imaginable. In his career, Sam has invented products, created brand experiences, written short- and long-form branded content, had his TVC scripts directed by Oscar® Winner Michel Gondry, and won a raft of industry awards – including gold at Cannes and the One Show. For the last 6 years, Sam has co-founded several brands of his own, including Canvino, Cangria, BUMP, Babycakes, Nudge Nudge Wink Wink, The CBD Guys, Humacology, MONDAY–SUNDAY and DiscoLabs. Sam is an active international speaker and thought-leader who has spoken at numerous creative conferences around the world – including 16 talks at Cannes Lions. During his ad career, he worked at M&C Saatchi, SS&K, JWT, VMLY&R, Apple, We Are Social – where he was the Chief Creation Officer for North America – as well as starting several agencies in NYC, one of which he sold to a private equity group. Sam’s also a co-founder of Hopeland, an orphan charity that he started with Deborra-Lee Jackman (Furness). After two years in both Los Angeles and Minneapolis followed by ten incredible years in years NYC, Sam is now based in Noosa Heads, Queensland, Melbourne and soon, Tokyo.
JAMES DALE
ジェームス・デール
JAMES DALE
経営統括責任者 / 共同創設者
CHIEF EXECUTIVE OFFICER + CO-FOUNDER
25歳で初の広告代理店をSaatchi & Saatchiに売却。ニュージーランド発祥のプレミアムウォッカブランド、42 Belowの共同創業者として米国市場に進出し、ブランド価値向上に尽力。数年後、バカルディ社に9桁規模で売却成功。独自ブランド戦略会社 Liquid Asset を設立し、複数ブランド（Dominique Rosé, Wodka Vodka, Cangria, Canvino, Captain Smolders Smoked Salmon、CBD・THC抽出施設）を市場投入。The CBD Guys および Humacology の主要パートナー。現在は Humacology のアジア・欧州展開を推進。拠点はブルックリン、プエルトリコ、ニュージーランド、オーストラリア。
James started his career in the advertising world, selling his first agency at age 25 to Saatchi & Saatchi after beating them to win the Procter & Gamble account. As a co-founder of 42 Below vodka, the USA and its huge market beckoned. He moved stateside and his work to build the brand’s equity there was instrumental in its near nine-figure sale price to Bacardi only a few years later. James then turned his attention to creating his own go-to-market brand practice, Liquid AssetÄi0, launching brands like Dominique Rosé, Wodka Vodka, Cangria, Canvino, Captain Smolders Smoked Salmon and our CBD and THC extraction facility. James and the facility are The CBD Guys’ + Humacology’s principal partners, and James and Sam are currently looking to expand Humacology to Asia and Europe. Today, James divides his time between Brooklyn, Puerto Rico, New Zealand and Australia.